Thursday - January 22, 2026

ZenaTech (ZENA) Expands Drone as a Service Fleet with Launch of Autonomous IQ Quad for Enterprise Surveys

Land surveying is a large, growing and underserved market,” stated Shaun Passley, Ph.D., ZenaTech CEO. “We believe the IQ Quad will significantly improve the productivity of our survey professionals while strengthening our vertically integrated DaaS platform and meaningfully expanding recurring … Continue reading

NK Cell Therapy Market 2034: 7MM Outlook, 30+ Active Developers, IND/NDA Momentum, and Next-Gen CAR-NK Innovations Driving Immunotherapy Advances | DelveInsight

NK Cell Therapy Market Major developers active in the NK cell therapy space include MiNK Therapeutics, Indapta Therapeutics, ImmunityBio, Inc., Allife Medical Science and Technology, Biohaven Pharmaceuticals, Acepodia, Bright Path Biotherapeutics, Amgen, Innate Pharma, Nektar Therapeutics, SMT bio Co., Ltd., … Continue reading

Marginal Zone Lymphoma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison

The Key Marginal Zone Lymphoma Companies in the market include – Bristol-Myers Squibb, TG Therapeutics, Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma, Beigene, Incyte Corporation, Enterome, and others. DelveInsight’s “Marginal Zone Lymphoma Market Insights, Epidemiology, … Continue reading